Name: EPPICON 2026 - Reimagining Healthy Aging: The Science, Startups and Business of Longevity
Start: 2026-10-17T00:00:00Z
End: 2026-10-17T00:00:00Z

EPPICON 2026 - Reimagining Healthy Aging: The Science, Startups and Business of Longevity

Affiliated Programs

Saturday, October 17, 2026

Crowne Plaza Foster City-San Mateo
Foster City, CA

More Information

Wilson Sonsini is pleased to sponsor EPPIC Global and the EPPICon 2026 annual meeting.

Be part of the life sciences community’s most dynamic gathering at EPPIC’s annual conference — where biotech, digital health, diagnostics, and medtech come together. More than just a conference, it’s a hub for leaders, founders, researchers, and investors to share insights, spark new ideas, and shape the future of healthcare innovation.

Aging is no longer simply something to slow down. It is a field to understand, shape, and build in.

For one day in the Bay Area, scientists, founders, clinicians, and investors working to extend healthspan will come together. EPPICON 2026, the flagship conference of EPPIC Global, will explore the science, clinical applications, and emerging businesses changing how we age.

On Saturday, October 17th, from 2:45-3:45 p.m., firm partner Deborah Smith will participate in the panel session, "Founders and Funders: Building the Longevity Economy."

Contacts

Katie Stonum

kstonum@wsgr.com

Presenters

Deborah M. Smith

Partner

San Diego

Deborah Smith leads Wilson Sonsini’s Patents and Innovations practice in Southern California. She advises high-growth biotechnology and pharmaceutical companies and their investors on IP strategy across the full product lifecycle—from platform development through drug approval, commercialization, and exit—spanning modalities including small molecules, ADCs, degraders, molecular glues, peptides, nucleic acid therapeutics, biologics, and protein conjugates. Her work spans patent strategy, portfolio development, IP due diligence, and IP matters tied to regulatory approval, as well as transactional matters including buy-side and sell-side M&A, licensing, financings, IPOs, and reverse mergers.